128 related articles for article (PubMed ID: 278177)
21. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
Hunder GG; McDuffie FC; Clark RJ
J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
[TBL] [Abstract][Full Text] [Related]
22. Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.
Romano C; Del Mastro A; Sellitto A; Solaro E; Esposito S; Cuomo G
Clin Rheumatol; 2018 Jun; 37(6):1695-1700. PubMed ID: 29362962
[TBL] [Abstract][Full Text] [Related]
23. Immunochemical quantitation of complement components of Clq and C3 in sera and synovial fluids of patients with bone and joint diseases.
Ochi T; Yonemasu K; Ono K
Ann Rheum Dis; 1980 Jun; 39(3):235-40. PubMed ID: 6774672
[TBL] [Abstract][Full Text] [Related]
24. Complement-activating properties of IgM rheumatoid factors reacting with IgG subclasses.
Sato Y; Watanabe H; Kogure A; Miyata M; Watanabe K; Nishimaki T; Kasukawa R; Fujita T
Clin Rheumatol; 1995 Jul; 14(4):425-8. PubMed ID: 7586979
[TBL] [Abstract][Full Text] [Related]
25. [An immunochemical study of extracts from synovial fluid cells in rheumatoid arthritis].
Kataoka Y
Nihon Seikeigeka Gakkai Zasshi; 1986 Mar; 60(3):287-94. PubMed ID: 3088186
[TBL] [Abstract][Full Text] [Related]
26. [Immunological findings in serum and synovial fluid in patients with rheumatoid arthritis (author's transl)].
Stojan B; Hasler F
Wien Klin Wochenschr; 1977 Nov; 89(21):713-6. PubMed ID: 919557
[TBL] [Abstract][Full Text] [Related]
27. Effects of gold therapy on the synthesis and quantity of serum and synovial fluid IgM, IgG, and IgA rheumatoid factors in rheumatoid arthritis patients.
Hanly JG; Hassan J; Whelan A; Feighery C; Bresnihan B
Arthritis Rheum; 1986 Apr; 29(4):480-7. PubMed ID: 3707625
[TBL] [Abstract][Full Text] [Related]
28. Depressed synovial fluid levels of properdin and properdin factor B in patients with rheumatoid arthritis.
Ruddy S; Fearon DT; Austen KF
Arthritis Rheum; 1975; 18(4):289-95. PubMed ID: 808229
[TBL] [Abstract][Full Text] [Related]
29. [Complement and immunoglobulins in rheumatoid arthritis].
Tanner E; Kühn RA; Kunath H; Stelzner A
Allerg Immunol (Leipz); 1974-1975; 20-21(1):73-6. PubMed ID: 4282832
[No Abstract] [Full Text] [Related]
30. [Critical considerations on the behavior of immunoglobulins in rheumatoid arthritis].
Troise W; Riccardi L; Bulgarelli G; Sesenna G; Ambanelli U
Ateneo Parmense Acta Biomed; 1975; 46(3):149-61. PubMed ID: 1156463
[TBL] [Abstract][Full Text] [Related]
31. Activation of the complement and properdin systems in rheumatoid arthritis.
Ruddy S; Austen KF
Ann N Y Acad Sci; 1975 Jun; 256():96-104. PubMed ID: 1099964
[TBL] [Abstract][Full Text] [Related]
32. Elevated C3 anaphylatoxin levels in synovial fluids from patients with rheumatoid arthritis.
Moxley G; Ruddy S
Arthritis Rheum; 1985 Oct; 28(10):1089-95. PubMed ID: 3876836
[TBL] [Abstract][Full Text] [Related]
33. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
[TBL] [Abstract][Full Text] [Related]
34. [Clinical value of immunoglobulin and complement determination in rheumatoid arthritis].
Bóhrer G; Ambrus M; Bajtai G; Kapisinszky N; Balogh Z
Orv Hetil; 1978 Aug; 119(32):1959-62. PubMed ID: 673413
[No Abstract] [Full Text] [Related]
35. Serum complement and immunoglobulin levels in sporadic and familial ankylosing spondylitis.
Kinsella TD; Espinoza L; Vasey FB
J Rheumatol; 1975 Sep; 2(3):308-13. PubMed ID: 1185743
[TBL] [Abstract][Full Text] [Related]
36. [Converse changes in serum levels of immunoglobulins (IgG, A and M) and complement components (C3, 4) during pregnancy].
Yasuhara M; Tamaki H; Iyama S; Yamaguchi Y; Amino N; Miyai K
Rinsho Byori; 1991 Nov; 39(11):1195-8. PubMed ID: 1762197
[TBL] [Abstract][Full Text] [Related]
37. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
38. Immunoelectrophoretic assay for synovial fluid C3 with correction for synovial fluid globulin.
Hasselbacher P
Arthritis Rheum; 1979 Mar; 22(3):243-50. PubMed ID: 105740
[TBL] [Abstract][Full Text] [Related]
39. Serum and synovial fluid IgG, IgA and IgM antigammaglobulins in rheumatoid arthritis.
Panush RS; Bianco NE; Schur PH
Arthritis Rheum; 1971; 14(6):737-47. PubMed ID: 5316357
[No Abstract] [Full Text] [Related]
40. Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.
Bedwell AE; Elson CJ; Carter SD; Dieppe PA; Hutton CW; Czudek R
Ann Rheum Dis; 1987 Jan; 46(1):55-64. PubMed ID: 3492971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
